These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11878792)

  • 1. Pancreatic surgical complications--the case for prophylaxis.
    Gouillat C; Gigot JF
    Gut; 2001 Dec; 49 Suppl 4(Suppl 4):iv32-9. PubMed ID: 11878792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin for the prevention of complications following pancreatoduodenectomy.
    Gouillat C
    Digestion; 1999; 60 Suppl 3():59-63. PubMed ID: 10567790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is octreotide beneficial in patients undergoing pancreaticoduodenectomy? Best evidence topic (BET).
    Drymousis P; Pai M; Spalding D; Jiao LR; Habib N; Zacharakis E
    Int J Surg; 2013; 11(9):779-82. PubMed ID: 23800512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials.
    Li-Ling J; Irving M
    Br J Surg; 2001 Feb; 88(2):190-9. PubMed ID: 11167865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of somatostatin and somatostatin analogues in the treatment of gastrointestinal diseases: prevention of complications after pancreatic surgery.
    Bassi C; Falconi M; Pederzoli P
    Gut; 1994; 35(3 Suppl):S20-2. PubMed ID: 7911443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy.
    You DD; Paik KY; Park IY; Yoo YK
    Asian J Surg; 2019 Feb; 42(2):458-463. PubMed ID: 30262436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide and postoperative pancreatic fistula after pancreaticoduodenectomy: What we know so far? A narrative review.
    Tilak M; Tewari M; Shukla HS
    Indian J Cancer; 2023; 60(2):152-159. PubMed ID: 37530235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of somatostatin and its analogues in pancreatic surgery and pancreatic disorders.
    Friess H; Büchler MW
    Digestion; 1996; 57 Suppl 1():97-102. PubMed ID: 8813484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and meta-analysis of somatostatin analogues in the prevention of postoperative complication after pancreaticoduodenectomy.
    Jin K; Zhou H; Zhang J; Wang W; Sun Y; Ruan C; Hu Z; Wang Y
    Dig Surg; 2015; 32(3):196-207. PubMed ID: 25872003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
    Nakatsuka A; Yamaguchi K; Chijiiwa K; Tanaka M
    Int Surg; 2000; 85(2):124-9. PubMed ID: 11071328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of octreotide and somatostatin in acute and chronic pancreatitis.
    Uhl W; Anghelacopoulos SE; Friess H; Büchler MW
    Digestion; 1999; 60 Suppl 2():23-31. PubMed ID: 10207228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review.
    Koti RS; Gurusamy KS; Fusai G; Davidson BR
    HPB (Oxford); 2010 Apr; 12(3):155-65. PubMed ID: 20590882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery.
    Droeser RA; Jeanmonod P; Schuld J; Moussavian MR; Schilling MK; Kollmar O
    Dig Surg; 2012; 29(6):484-91. PubMed ID: 23392293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of postoperative complications following pancreatic surgery.
    Büchler M; Friess H
    Digestion; 1993; 54 Suppl 1():41-6. PubMed ID: 8103013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of somatostatin and its analogues in prevention of postoperative complications after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials.
    Zeng Q; Zhang Q; Han S; Yu Z; Zheng M; Zhou M; Bai J; Jin R
    Pancreas; 2008 Jan; 36(1):18-25. PubMed ID: 18192875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of pancreatic fistula after cephalic duodenopancreatectomy].
    Sauvanet A; Belghiti J
    Ann Chir; 1999; 53(7):612-7. PubMed ID: 10520501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pancreaticojejunal anastomosis: the "Achilles heel" of pancreaticoduodenectomy].
    Gulbinas A; Barauskas G; Pundzius J
    Medicina (Kaunas); 2004; 40(10):927-34. PubMed ID: 15516814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial comparing somatostatin with octreotide in the prevention of complications after pancreatectomy.
    Closset J; Journe S; Mboti F; El Nakadi I; Gelin M
    Hepatogastroenterology; 2008; 55(86-87):1818-23. PubMed ID: 19102400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review.
    Lai EC; Lau SH; Lau WY
    Arch Surg; 2009 Nov; 144(11):1074-80. PubMed ID: 19917946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Germany.
    Fiess H; Klempa I; Hermanek P; Sulkowski U; Uhl W; Beger HG; Büchler MW
    Digestion; 1994; 55 Suppl 1():35-40. PubMed ID: 8132135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.